Global Modified Live Vaccine Supply, Demand and Key Producers, 2026-2032
The global Modified Live Vaccine market size is expected to reach $ 826 million by 2032, rising at a market growth of 6.8% CAGR during the forecast period (2026-2032).
In 2025, global Modified Live Vaccine approximately 22,364 k doses, with an average global market price of around US$ 24 per dose. Gross margin is about 47%. The cost is 13 usd. The Production is about 25,000 k doses. A Modified Live Vaccine is a type of live vaccine made from a pathogen that has been weakened or genetically modified to reduce its ability to cause disease while retaining limited replication capability. After administration, it can mimic natural infection and stimulate strong and long-lasting immune responses in animals. Modified live vaccines are widely used in disease prevention for swine, cattle, sheep, poultry, and companion animals. Compared with inactivated vaccines, they usually provide stronger and faster immunity with lower doses, but they require stricter control over storage, transportation, safety, and strain stability.
Modified live vaccines will develop toward improved safety, stability, and precision. As large-scale farming and animal disease prevention requirements continue to increase, manufacturers will focus more on attenuation stability, control of reversion-to-virulence risk, duration of immunity, and cross-protection capability. Genetic attenuation, reverse genetics, vector-based vaccines, and multivalent combination vaccines will become important R&D directions, enabling broader protection against multiple pathogens or serotypes and improving immune efficacy across swine, cattle, sheep, poultry, and companion animals. At the same time, cold-chain stability, freeze-drying processes, and mass administration methods such as spray, drinking water, and intranasal delivery will continue to improve, reducing vaccination costs and increasing efficiency in large-scale applications.
This report studies the global Modified Live Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Modified Live Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Modified Live Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Modified Live Vaccine total production and demand, 2021-2032, (K Dose)
Global Modified Live Vaccine total production value, 2021-2032, (USD Million)
Global Modified Live Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Modified Live Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Modified Live Vaccine domestic production, consumption, key domestic manufacturers and share
Global Modified Live Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Modified Live Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Modified Live Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Modified Live Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Ceva Sant? Animale, Boehringer Ingelheim Animal Health, MSD Animal Health, Virbac, HIPRA, Vetoquinol, Phibro Animal Health, IDT Biologika, Vaxxinova, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Modified Live Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Modified Live Vaccine Market, By Region:
1. How big is the global Modified Live Vaccine market?
2. What is the demand of the global Modified Live Vaccine market?
3. What is the year over year growth of the global Modified Live Vaccine market?
4. What is the production and production value of the global Modified Live Vaccine market?
5. Who are the key producers in the global Modified Live Vaccine market?
6. What are the growth factors driving the market demand?
In 2025, global Modified Live Vaccine approximately 22,364 k doses, with an average global market price of around US$ 24 per dose. Gross margin is about 47%. The cost is 13 usd. The Production is about 25,000 k doses. A Modified Live Vaccine is a type of live vaccine made from a pathogen that has been weakened or genetically modified to reduce its ability to cause disease while retaining limited replication capability. After administration, it can mimic natural infection and stimulate strong and long-lasting immune responses in animals. Modified live vaccines are widely used in disease prevention for swine, cattle, sheep, poultry, and companion animals. Compared with inactivated vaccines, they usually provide stronger and faster immunity with lower doses, but they require stricter control over storage, transportation, safety, and strain stability.
Modified live vaccines will develop toward improved safety, stability, and precision. As large-scale farming and animal disease prevention requirements continue to increase, manufacturers will focus more on attenuation stability, control of reversion-to-virulence risk, duration of immunity, and cross-protection capability. Genetic attenuation, reverse genetics, vector-based vaccines, and multivalent combination vaccines will become important R&D directions, enabling broader protection against multiple pathogens or serotypes and improving immune efficacy across swine, cattle, sheep, poultry, and companion animals. At the same time, cold-chain stability, freeze-drying processes, and mass administration methods such as spray, drinking water, and intranasal delivery will continue to improve, reducing vaccination costs and increasing efficiency in large-scale applications.
This report studies the global Modified Live Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Modified Live Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Modified Live Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Modified Live Vaccine total production and demand, 2021-2032, (K Dose)
Global Modified Live Vaccine total production value, 2021-2032, (USD Million)
Global Modified Live Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Modified Live Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Modified Live Vaccine domestic production, consumption, key domestic manufacturers and share
Global Modified Live Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Modified Live Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Modified Live Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Modified Live Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Ceva Sant? Animale, Boehringer Ingelheim Animal Health, MSD Animal Health, Virbac, HIPRA, Vetoquinol, Phibro Animal Health, IDT Biologika, Vaxxinova, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Modified Live Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Modified Live Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monovalent Live Attenuated Vaccines
- Multivalent Live Attenuated Vaccines
- Combination Live Attenuated Vaccines
- Viral Live Attenuated Vaccines
- Bacterial Live Attenuated Vaccines
- Parasitic Live Attenuated Vaccines
- Livestock
- Poultry
- Companion Animals
- Others
- Zoetis
- Ceva Sant? Animale
- Boehringer Ingelheim Animal Health
- MSD Animal Health
- Virbac
- HIPRA
- Vetoquinol
- Phibro Animal Health
- IDT Biologika
- Vaxxinova
- KBNP Inc.
- China Pharmaceutical Group Animal Health Co., Ltd.
- Jinyu Bio-technology Co., Ltd.
1. How big is the global Modified Live Vaccine market?
2. What is the demand of the global Modified Live Vaccine market?
3. What is the year over year growth of the global Modified Live Vaccine market?
4. What is the production and production value of the global Modified Live Vaccine market?
5. Who are the key producers in the global Modified Live Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Modified Live Vaccine Introduction
1.2 World Modified Live Vaccine Supply & Forecast
1.2.1 World Modified Live Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Modified Live Vaccine Production (2021-2032)
1.2.3 World Modified Live Vaccine Pricing Trends (2021-2032)
1.3 World Modified Live Vaccine Production by Region (Based on Production Site)
1.3.1 World Modified Live Vaccine Production Value by Region (2021-2032)
1.3.2 World Modified Live Vaccine Production by Region (2021-2032)
1.3.3 World Modified Live Vaccine Average Price by Region (2021-2032)
1.3.4 North America Modified Live Vaccine Production (2021-2032)
1.3.5 Europe Modified Live Vaccine Production (2021-2032)
1.3.6 China Modified Live Vaccine Production (2021-2032)
1.3.7 Japan Modified Live Vaccine Production (2021-2032)
1.3.8 India Modified Live Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Modified Live Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Modified Live Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Modified Live Vaccine Demand (2021-2032)
2.2 World Modified Live Vaccine Consumption by Region
2.2.1 World Modified Live Vaccine Consumption by Region (2021-2026)
2.2.2 World Modified Live Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Modified Live Vaccine Consumption (2021-2032)
2.4 China Modified Live Vaccine Consumption (2021-2032)
2.5 Europe Modified Live Vaccine Consumption (2021-2032)
2.6 Japan Modified Live Vaccine Consumption (2021-2032)
2.7 South Korea Modified Live Vaccine Consumption (2021-2032)
2.8 ASEAN Modified Live Vaccine Consumption (2021-2032)
2.9 India Modified Live Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Modified Live Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Modified Live Vaccine Production by Manufacturer (2021-2026)
3.3 World Modified Live Vaccine Average Price by Manufacturer (2021-2026)
3.4 Modified Live Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Modified Live Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Modified Live Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Modified Live Vaccine in 2025
3.6 Modified Live Vaccine Market: Overall Company Footprint Analysis
3.6.1 Modified Live Vaccine Market: Region Footprint
3.6.2 Modified Live Vaccine Market: Company Product Type Footprint
3.6.3 Modified Live Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Modified Live Vaccine Production Value Comparison
4.1.1 United States VS China: Modified Live Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Modified Live Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Modified Live Vaccine Production Comparison
4.2.1 United States VS China: Modified Live Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Modified Live Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Modified Live Vaccine Consumption Comparison
4.3.1 United States VS China: Modified Live Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Modified Live Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Modified Live Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Modified Live Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Modified Live Vaccine Production (2021-2026)
4.5 China Based Modified Live Vaccine Manufacturers and Market Share
4.5.1 China Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Modified Live Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Modified Live Vaccine Production (2021-2026)
4.6 Rest of World Based Modified Live Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Modified Live Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Modified Live Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Modified Live Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Monovalent Live Attenuated Vaccines
5.2.2 Multivalent Live Attenuated Vaccines
5.2.3 Combination Live Attenuated Vaccines
5.3 Market Segment by Type
5.3.1 World Modified Live Vaccine Production by Type (2021-2032)
5.3.2 World Modified Live Vaccine Production Value by Type (2021-2032)
5.3.3 World Modified Live Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PATHOGEN
6.1 World Modified Live Vaccine Market Size Overview by Pathogen: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Pathogen
6.2.1 Viral Live Attenuated Vaccines
6.2.2 Bacterial Live Attenuated Vaccines
6.2.3 Parasitic Live Attenuated Vaccines
6.3 Market Segment by Pathogen
6.3.1 World Modified Live Vaccine Production by Pathogen (2021-2032)
6.3.2 World Modified Live Vaccine Production Value by Pathogen (2021-2032)
6.3.3 World Modified Live Vaccine Average Price by Pathogen (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Modified Live Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Livestock
7.2.2 Poultry
7.2.3 Companion Animals
7.2.4 Others
7.3 Market Segment by Application
7.3.1 World Modified Live Vaccine Production by Application (2021-2032)
7.3.2 World Modified Live Vaccine Production Value by Application (2021-2032)
7.3.3 World Modified Live Vaccine Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Zoetis
8.1.1 Zoetis Details
8.1.2 Zoetis Major Business
8.1.3 Zoetis Modified Live Vaccine Product and Services
8.1.4 Zoetis Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Zoetis Recent Developments/Updates
8.1.6 Zoetis Competitive Strengths & Weaknesses
8.2 Ceva Sant? Animale
8.2.1 Ceva Sant? Animale Details
8.2.2 Ceva Sant? Animale Major Business
8.2.3 Ceva Sant? Animale Modified Live Vaccine Product and Services
8.2.4 Ceva Sant? Animale Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Ceva Sant? Animale Recent Developments/Updates
8.2.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
8.3 Boehringer Ingelheim Animal Health
8.3.1 Boehringer Ingelheim Animal Health Details
8.3.2 Boehringer Ingelheim Animal Health Major Business
8.3.3 Boehringer Ingelheim Animal Health Modified Live Vaccine Product and Services
8.3.4 Boehringer Ingelheim Animal Health Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
8.3.6 Boehringer Ingelheim Animal Health Competitive Strengths & Weaknesses
8.4 MSD Animal Health
8.4.1 MSD Animal Health Details
8.4.2 MSD Animal Health Major Business
8.4.3 MSD Animal Health Modified Live Vaccine Product and Services
8.4.4 MSD Animal Health Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 MSD Animal Health Recent Developments/Updates
8.4.6 MSD Animal Health Competitive Strengths & Weaknesses
8.5 Virbac
8.5.1 Virbac Details
8.5.2 Virbac Major Business
8.5.3 Virbac Modified Live Vaccine Product and Services
8.5.4 Virbac Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Virbac Recent Developments/Updates
8.5.6 Virbac Competitive Strengths & Weaknesses
8.6 HIPRA
8.6.1 HIPRA Details
8.6.2 HIPRA Major Business
8.6.3 HIPRA Modified Live Vaccine Product and Services
8.6.4 HIPRA Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 HIPRA Recent Developments/Updates
8.6.6 HIPRA Competitive Strengths & Weaknesses
8.7 Vetoquinol
8.7.1 Vetoquinol Details
8.7.2 Vetoquinol Major Business
8.7.3 Vetoquinol Modified Live Vaccine Product and Services
8.7.4 Vetoquinol Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Vetoquinol Recent Developments/Updates
8.7.6 Vetoquinol Competitive Strengths & Weaknesses
8.8 Phibro Animal Health
8.8.1 Phibro Animal Health Details
8.8.2 Phibro Animal Health Major Business
8.8.3 Phibro Animal Health Modified Live Vaccine Product and Services
8.8.4 Phibro Animal Health Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Phibro Animal Health Recent Developments/Updates
8.8.6 Phibro Animal Health Competitive Strengths & Weaknesses
8.9 IDT Biologika
8.9.1 IDT Biologika Details
8.9.2 IDT Biologika Major Business
8.9.3 IDT Biologika Modified Live Vaccine Product and Services
8.9.4 IDT Biologika Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 IDT Biologika Recent Developments/Updates
8.9.6 IDT Biologika Competitive Strengths & Weaknesses
8.10 Vaxxinova
8.10.1 Vaxxinova Details
8.10.2 Vaxxinova Major Business
8.10.3 Vaxxinova Modified Live Vaccine Product and Services
8.10.4 Vaxxinova Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Vaxxinova Recent Developments/Updates
8.10.6 Vaxxinova Competitive Strengths & Weaknesses
8.11 KBNP Inc.
8.11.1 KBNP Inc. Details
8.11.2 KBNP Inc. Major Business
8.11.3 KBNP Inc. Modified Live Vaccine Product and Services
8.11.4 KBNP Inc. Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 KBNP Inc. Recent Developments/Updates
8.11.6 KBNP Inc. Competitive Strengths & Weaknesses
8.12 China Pharmaceutical Group Animal Health Co., Ltd.
8.12.1 China Pharmaceutical Group Animal Health Co., Ltd. Details
8.12.2 China Pharmaceutical Group Animal Health Co., Ltd. Major Business
8.12.3 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product and Services
8.12.4 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 China Pharmaceutical Group Animal Health Co., Ltd. Recent Developments/Updates
8.12.6 China Pharmaceutical Group Animal Health Co., Ltd. Competitive Strengths & Weaknesses
8.13 Jinyu Bio-technology Co., Ltd.
8.13.1 Jinyu Bio-technology Co., Ltd. Details
8.13.2 Jinyu Bio-technology Co., Ltd. Major Business
8.13.3 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product and Services
8.13.4 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 Jinyu Bio-technology Co., Ltd. Recent Developments/Updates
8.13.6 Jinyu Bio-technology Co., Ltd. Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Modified Live Vaccine Industry Chain
9.2 Modified Live Vaccine Upstream Analysis
9.2.1 Modified Live Vaccine Core Raw Materials
9.2.2 Main Manufacturers of Modified Live Vaccine Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Modified Live Vaccine Production Mode
9.6 Modified Live Vaccine Procurement Model
9.7 Modified Live Vaccine Industry Sales Model and Sales Channels
9.7.1 Modified Live Vaccine Sales Model
9.7.2 Modified Live Vaccine Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Modified Live Vaccine Introduction
1.2 World Modified Live Vaccine Supply & Forecast
1.2.1 World Modified Live Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Modified Live Vaccine Production (2021-2032)
1.2.3 World Modified Live Vaccine Pricing Trends (2021-2032)
1.3 World Modified Live Vaccine Production by Region (Based on Production Site)
1.3.1 World Modified Live Vaccine Production Value by Region (2021-2032)
1.3.2 World Modified Live Vaccine Production by Region (2021-2032)
1.3.3 World Modified Live Vaccine Average Price by Region (2021-2032)
1.3.4 North America Modified Live Vaccine Production (2021-2032)
1.3.5 Europe Modified Live Vaccine Production (2021-2032)
1.3.6 China Modified Live Vaccine Production (2021-2032)
1.3.7 Japan Modified Live Vaccine Production (2021-2032)
1.3.8 India Modified Live Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Modified Live Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Modified Live Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Modified Live Vaccine Demand (2021-2032)
2.2 World Modified Live Vaccine Consumption by Region
2.2.1 World Modified Live Vaccine Consumption by Region (2021-2026)
2.2.2 World Modified Live Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Modified Live Vaccine Consumption (2021-2032)
2.4 China Modified Live Vaccine Consumption (2021-2032)
2.5 Europe Modified Live Vaccine Consumption (2021-2032)
2.6 Japan Modified Live Vaccine Consumption (2021-2032)
2.7 South Korea Modified Live Vaccine Consumption (2021-2032)
2.8 ASEAN Modified Live Vaccine Consumption (2021-2032)
2.9 India Modified Live Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Modified Live Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Modified Live Vaccine Production by Manufacturer (2021-2026)
3.3 World Modified Live Vaccine Average Price by Manufacturer (2021-2026)
3.4 Modified Live Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Modified Live Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Modified Live Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Modified Live Vaccine in 2025
3.6 Modified Live Vaccine Market: Overall Company Footprint Analysis
3.6.1 Modified Live Vaccine Market: Region Footprint
3.6.2 Modified Live Vaccine Market: Company Product Type Footprint
3.6.3 Modified Live Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Modified Live Vaccine Production Value Comparison
4.1.1 United States VS China: Modified Live Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Modified Live Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Modified Live Vaccine Production Comparison
4.2.1 United States VS China: Modified Live Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Modified Live Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Modified Live Vaccine Consumption Comparison
4.3.1 United States VS China: Modified Live Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Modified Live Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Modified Live Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Modified Live Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Modified Live Vaccine Production (2021-2026)
4.5 China Based Modified Live Vaccine Manufacturers and Market Share
4.5.1 China Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Modified Live Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Modified Live Vaccine Production (2021-2026)
4.6 Rest of World Based Modified Live Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Modified Live Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Modified Live Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Modified Live Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Monovalent Live Attenuated Vaccines
5.2.2 Multivalent Live Attenuated Vaccines
5.2.3 Combination Live Attenuated Vaccines
5.3 Market Segment by Type
5.3.1 World Modified Live Vaccine Production by Type (2021-2032)
5.3.2 World Modified Live Vaccine Production Value by Type (2021-2032)
5.3.3 World Modified Live Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PATHOGEN
6.1 World Modified Live Vaccine Market Size Overview by Pathogen: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Pathogen
6.2.1 Viral Live Attenuated Vaccines
6.2.2 Bacterial Live Attenuated Vaccines
6.2.3 Parasitic Live Attenuated Vaccines
6.3 Market Segment by Pathogen
6.3.1 World Modified Live Vaccine Production by Pathogen (2021-2032)
6.3.2 World Modified Live Vaccine Production Value by Pathogen (2021-2032)
6.3.3 World Modified Live Vaccine Average Price by Pathogen (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Modified Live Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Livestock
7.2.2 Poultry
7.2.3 Companion Animals
7.2.4 Others
7.3 Market Segment by Application
7.3.1 World Modified Live Vaccine Production by Application (2021-2032)
7.3.2 World Modified Live Vaccine Production Value by Application (2021-2032)
7.3.3 World Modified Live Vaccine Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Zoetis
8.1.1 Zoetis Details
8.1.2 Zoetis Major Business
8.1.3 Zoetis Modified Live Vaccine Product and Services
8.1.4 Zoetis Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Zoetis Recent Developments/Updates
8.1.6 Zoetis Competitive Strengths & Weaknesses
8.2 Ceva Sant? Animale
8.2.1 Ceva Sant? Animale Details
8.2.2 Ceva Sant? Animale Major Business
8.2.3 Ceva Sant? Animale Modified Live Vaccine Product and Services
8.2.4 Ceva Sant? Animale Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Ceva Sant? Animale Recent Developments/Updates
8.2.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
8.3 Boehringer Ingelheim Animal Health
8.3.1 Boehringer Ingelheim Animal Health Details
8.3.2 Boehringer Ingelheim Animal Health Major Business
8.3.3 Boehringer Ingelheim Animal Health Modified Live Vaccine Product and Services
8.3.4 Boehringer Ingelheim Animal Health Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
8.3.6 Boehringer Ingelheim Animal Health Competitive Strengths & Weaknesses
8.4 MSD Animal Health
8.4.1 MSD Animal Health Details
8.4.2 MSD Animal Health Major Business
8.4.3 MSD Animal Health Modified Live Vaccine Product and Services
8.4.4 MSD Animal Health Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 MSD Animal Health Recent Developments/Updates
8.4.6 MSD Animal Health Competitive Strengths & Weaknesses
8.5 Virbac
8.5.1 Virbac Details
8.5.2 Virbac Major Business
8.5.3 Virbac Modified Live Vaccine Product and Services
8.5.4 Virbac Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Virbac Recent Developments/Updates
8.5.6 Virbac Competitive Strengths & Weaknesses
8.6 HIPRA
8.6.1 HIPRA Details
8.6.2 HIPRA Major Business
8.6.3 HIPRA Modified Live Vaccine Product and Services
8.6.4 HIPRA Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 HIPRA Recent Developments/Updates
8.6.6 HIPRA Competitive Strengths & Weaknesses
8.7 Vetoquinol
8.7.1 Vetoquinol Details
8.7.2 Vetoquinol Major Business
8.7.3 Vetoquinol Modified Live Vaccine Product and Services
8.7.4 Vetoquinol Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Vetoquinol Recent Developments/Updates
8.7.6 Vetoquinol Competitive Strengths & Weaknesses
8.8 Phibro Animal Health
8.8.1 Phibro Animal Health Details
8.8.2 Phibro Animal Health Major Business
8.8.3 Phibro Animal Health Modified Live Vaccine Product and Services
8.8.4 Phibro Animal Health Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Phibro Animal Health Recent Developments/Updates
8.8.6 Phibro Animal Health Competitive Strengths & Weaknesses
8.9 IDT Biologika
8.9.1 IDT Biologika Details
8.9.2 IDT Biologika Major Business
8.9.3 IDT Biologika Modified Live Vaccine Product and Services
8.9.4 IDT Biologika Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 IDT Biologika Recent Developments/Updates
8.9.6 IDT Biologika Competitive Strengths & Weaknesses
8.10 Vaxxinova
8.10.1 Vaxxinova Details
8.10.2 Vaxxinova Major Business
8.10.3 Vaxxinova Modified Live Vaccine Product and Services
8.10.4 Vaxxinova Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Vaxxinova Recent Developments/Updates
8.10.6 Vaxxinova Competitive Strengths & Weaknesses
8.11 KBNP Inc.
8.11.1 KBNP Inc. Details
8.11.2 KBNP Inc. Major Business
8.11.3 KBNP Inc. Modified Live Vaccine Product and Services
8.11.4 KBNP Inc. Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 KBNP Inc. Recent Developments/Updates
8.11.6 KBNP Inc. Competitive Strengths & Weaknesses
8.12 China Pharmaceutical Group Animal Health Co., Ltd.
8.12.1 China Pharmaceutical Group Animal Health Co., Ltd. Details
8.12.2 China Pharmaceutical Group Animal Health Co., Ltd. Major Business
8.12.3 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product and Services
8.12.4 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 China Pharmaceutical Group Animal Health Co., Ltd. Recent Developments/Updates
8.12.6 China Pharmaceutical Group Animal Health Co., Ltd. Competitive Strengths & Weaknesses
8.13 Jinyu Bio-technology Co., Ltd.
8.13.1 Jinyu Bio-technology Co., Ltd. Details
8.13.2 Jinyu Bio-technology Co., Ltd. Major Business
8.13.3 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product and Services
8.13.4 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 Jinyu Bio-technology Co., Ltd. Recent Developments/Updates
8.13.6 Jinyu Bio-technology Co., Ltd. Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Modified Live Vaccine Industry Chain
9.2 Modified Live Vaccine Upstream Analysis
9.2.1 Modified Live Vaccine Core Raw Materials
9.2.2 Main Manufacturers of Modified Live Vaccine Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Modified Live Vaccine Production Mode
9.6 Modified Live Vaccine Procurement Model
9.7 Modified Live Vaccine Industry Sales Model and Sales Channels
9.7.1 Modified Live Vaccine Sales Model
9.7.2 Modified Live Vaccine Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Modified Live Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Modified Live Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Modified Live Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Modified Live Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Modified Live Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Modified Live Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Modified Live Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Modified Live Vaccine Production Market Share by Region (2021-2026)
Table 9. World Modified Live Vaccine Production Market Share by Region (2027-2032)
Table 10. World Modified Live Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Modified Live Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Modified Live Vaccine Major Market Trends
Table 13. World Modified Live Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Modified Live Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Modified Live Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Modified Live Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Modified Live Vaccine Producers in 2025
Table 18. World Modified Live Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Modified Live Vaccine Producers in 2025
Table 20. World Modified Live Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Modified Live Vaccine Company Evaluation Quadrant
Table 22. World Modified Live Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Modified Live Vaccine Production Site of Key Manufacturer
Table 24. Modified Live Vaccine Market: Company Product Type Footprint
Table 25. Modified Live Vaccine Market: Company Product Application Footprint
Table 26. Modified Live Vaccine Competitive Factors
Table 27. Modified Live Vaccine New Entrant and Capacity Expansion Plans
Table 28. Modified Live Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Modified Live Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Modified Live Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Modified Live Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Modified Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Modified Live Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Modified Live Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Modified Live Vaccine Production Market Share (2021-2026)
Table 37. China Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Modified Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Modified Live Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Modified Live Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Modified Live Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Modified Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Modified Live Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Modified Live Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Modified Live Vaccine Production Market Share (2021-2026)
Table 47. World Modified Live Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Modified Live Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Modified Live Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Modified Live Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Modified Live Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Modified Live Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Modified Live Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Modified Live Vaccine Production Value by Pathogen, (USD Million), 2021 & 2025 & 2032
Table 55. World Modified Live Vaccine Production by Pathogen (2021-2026) & (K Dose)
Table 56. World Modified Live Vaccine Production by Pathogen (2027-2032) & (K Dose)
Table 57. World Modified Live Vaccine Production Value by Pathogen (2021-2026) & (USD Million)
Table 58. World Modified Live Vaccine Production Value by Pathogen (2027-2032) & (USD Million)
Table 59. World Modified Live Vaccine Average Price by Pathogen (2021-2026) & (US$/Dose)
Table 60. World Modified Live Vaccine Average Price by Pathogen (2027-2032) & (US$/Dose)
Table 61. World Modified Live Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Modified Live Vaccine Production by Application (2021-2026) & (K Dose)
Table 63. World Modified Live Vaccine Production by Application (2027-2032) & (K Dose)
Table 64. World Modified Live Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 65. World Modified Live Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 66. World Modified Live Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 67. World Modified Live Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 68. Zoetis Basic Information, Manufacturing Base and Competitors
Table 69. Zoetis Major Business
Table 70. Zoetis Modified Live Vaccine Product and Services
Table 71. Zoetis Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Zoetis Recent Developments/Updates
Table 73. Zoetis Competitive Strengths & Weaknesses
Table 74. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 75. Ceva Sant? Animale Major Business
Table 76. Ceva Sant? Animale Modified Live Vaccine Product and Services
Table 77. Ceva Sant? Animale Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Ceva Sant? Animale Recent Developments/Updates
Table 79. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 80. Boehringer Ingelheim Animal Health Basic Information, Manufacturing Base and Competitors
Table 81. Boehringer Ingelheim Animal Health Major Business
Table 82. Boehringer Ingelheim Animal Health Modified Live Vaccine Product and Services
Table 83. Boehringer Ingelheim Animal Health Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Boehringer Ingelheim Animal Health Recent Developments/Updates
Table 85. Boehringer Ingelheim Animal Health Competitive Strengths & Weaknesses
Table 86. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 87. MSD Animal Health Major Business
Table 88. MSD Animal Health Modified Live Vaccine Product and Services
Table 89. MSD Animal Health Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. MSD Animal Health Recent Developments/Updates
Table 91. MSD Animal Health Competitive Strengths & Weaknesses
Table 92. Virbac Basic Information, Manufacturing Base and Competitors
Table 93. Virbac Major Business
Table 94. Virbac Modified Live Vaccine Product and Services
Table 95. Virbac Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Virbac Recent Developments/Updates
Table 97. Virbac Competitive Strengths & Weaknesses
Table 98. HIPRA Basic Information, Manufacturing Base and Competitors
Table 99. HIPRA Major Business
Table 100. HIPRA Modified Live Vaccine Product and Services
Table 101. HIPRA Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. HIPRA Recent Developments/Updates
Table 103. HIPRA Competitive Strengths & Weaknesses
Table 104. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 105. Vetoquinol Major Business
Table 106. Vetoquinol Modified Live Vaccine Product and Services
Table 107. Vetoquinol Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Vetoquinol Recent Developments/Updates
Table 109. Vetoquinol Competitive Strengths & Weaknesses
Table 110. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
Table 111. Phibro Animal Health Major Business
Table 112. Phibro Animal Health Modified Live Vaccine Product and Services
Table 113. Phibro Animal Health Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Phibro Animal Health Recent Developments/Updates
Table 115. Phibro Animal Health Competitive Strengths & Weaknesses
Table 116. IDT Biologika Basic Information, Manufacturing Base and Competitors
Table 117. IDT Biologika Major Business
Table 118. IDT Biologika Modified Live Vaccine Product and Services
Table 119. IDT Biologika Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. IDT Biologika Recent Developments/Updates
Table 121. IDT Biologika Competitive Strengths & Weaknesses
Table 122. Vaxxinova Basic Information, Manufacturing Base and Competitors
Table 123. Vaxxinova Major Business
Table 124. Vaxxinova Modified Live Vaccine Product and Services
Table 125. Vaxxinova Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Vaxxinova Recent Developments/Updates
Table 127. Vaxxinova Competitive Strengths & Weaknesses
Table 128. KBNP Inc. Basic Information, Manufacturing Base and Competitors
Table 129. KBNP Inc. Major Business
Table 130. KBNP Inc. Modified Live Vaccine Product and Services
Table 131. KBNP Inc. Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. KBNP Inc. Recent Developments/Updates
Table 133. KBNP Inc. Competitive Strengths & Weaknesses
Table 134. China Pharmaceutical Group Animal Health Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 135. China Pharmaceutical Group Animal Health Co., Ltd. Major Business
Table 136. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product and Services
Table 137. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. China Pharmaceutical Group Animal Health Co., Ltd. Recent Developments/Updates
Table 139. China Pharmaceutical Group Animal Health Co., Ltd. Competitive Strengths & Weaknesses
Table 140. Jinyu Bio-technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 141. Jinyu Bio-technology Co., Ltd. Major Business
Table 142. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product and Services
Table 143. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Jinyu Bio-technology Co., Ltd. Recent Developments/Updates
Table 145. Jinyu Bio-technology Co., Ltd. Competitive Strengths & Weaknesses
Table 146. Global Key Players of Modified Live Vaccine Upstream (Raw Materials)
Table 147. Global Modified Live Vaccine Typical Customers
Table 148. Modified Live Vaccine Typical Distributors
Table 1. World Modified Live Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Modified Live Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Modified Live Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Modified Live Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Modified Live Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Modified Live Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Modified Live Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Modified Live Vaccine Production Market Share by Region (2021-2026)
Table 9. World Modified Live Vaccine Production Market Share by Region (2027-2032)
Table 10. World Modified Live Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Modified Live Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Modified Live Vaccine Major Market Trends
Table 13. World Modified Live Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Modified Live Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Modified Live Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Modified Live Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Modified Live Vaccine Producers in 2025
Table 18. World Modified Live Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Modified Live Vaccine Producers in 2025
Table 20. World Modified Live Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Modified Live Vaccine Company Evaluation Quadrant
Table 22. World Modified Live Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Modified Live Vaccine Production Site of Key Manufacturer
Table 24. Modified Live Vaccine Market: Company Product Type Footprint
Table 25. Modified Live Vaccine Market: Company Product Application Footprint
Table 26. Modified Live Vaccine Competitive Factors
Table 27. Modified Live Vaccine New Entrant and Capacity Expansion Plans
Table 28. Modified Live Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Modified Live Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Modified Live Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Modified Live Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Modified Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Modified Live Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Modified Live Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Modified Live Vaccine Production Market Share (2021-2026)
Table 37. China Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Modified Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Modified Live Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Modified Live Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Modified Live Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Modified Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Modified Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Modified Live Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Modified Live Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Modified Live Vaccine Production Market Share (2021-2026)
Table 47. World Modified Live Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Modified Live Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Modified Live Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Modified Live Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Modified Live Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Modified Live Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Modified Live Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Modified Live Vaccine Production Value by Pathogen, (USD Million), 2021 & 2025 & 2032
Table 55. World Modified Live Vaccine Production by Pathogen (2021-2026) & (K Dose)
Table 56. World Modified Live Vaccine Production by Pathogen (2027-2032) & (K Dose)
Table 57. World Modified Live Vaccine Production Value by Pathogen (2021-2026) & (USD Million)
Table 58. World Modified Live Vaccine Production Value by Pathogen (2027-2032) & (USD Million)
Table 59. World Modified Live Vaccine Average Price by Pathogen (2021-2026) & (US$/Dose)
Table 60. World Modified Live Vaccine Average Price by Pathogen (2027-2032) & (US$/Dose)
Table 61. World Modified Live Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Modified Live Vaccine Production by Application (2021-2026) & (K Dose)
Table 63. World Modified Live Vaccine Production by Application (2027-2032) & (K Dose)
Table 64. World Modified Live Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 65. World Modified Live Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 66. World Modified Live Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 67. World Modified Live Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 68. Zoetis Basic Information, Manufacturing Base and Competitors
Table 69. Zoetis Major Business
Table 70. Zoetis Modified Live Vaccine Product and Services
Table 71. Zoetis Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Zoetis Recent Developments/Updates
Table 73. Zoetis Competitive Strengths & Weaknesses
Table 74. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 75. Ceva Sant? Animale Major Business
Table 76. Ceva Sant? Animale Modified Live Vaccine Product and Services
Table 77. Ceva Sant? Animale Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Ceva Sant? Animale Recent Developments/Updates
Table 79. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 80. Boehringer Ingelheim Animal Health Basic Information, Manufacturing Base and Competitors
Table 81. Boehringer Ingelheim Animal Health Major Business
Table 82. Boehringer Ingelheim Animal Health Modified Live Vaccine Product and Services
Table 83. Boehringer Ingelheim Animal Health Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Boehringer Ingelheim Animal Health Recent Developments/Updates
Table 85. Boehringer Ingelheim Animal Health Competitive Strengths & Weaknesses
Table 86. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 87. MSD Animal Health Major Business
Table 88. MSD Animal Health Modified Live Vaccine Product and Services
Table 89. MSD Animal Health Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. MSD Animal Health Recent Developments/Updates
Table 91. MSD Animal Health Competitive Strengths & Weaknesses
Table 92. Virbac Basic Information, Manufacturing Base and Competitors
Table 93. Virbac Major Business
Table 94. Virbac Modified Live Vaccine Product and Services
Table 95. Virbac Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Virbac Recent Developments/Updates
Table 97. Virbac Competitive Strengths & Weaknesses
Table 98. HIPRA Basic Information, Manufacturing Base and Competitors
Table 99. HIPRA Major Business
Table 100. HIPRA Modified Live Vaccine Product and Services
Table 101. HIPRA Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. HIPRA Recent Developments/Updates
Table 103. HIPRA Competitive Strengths & Weaknesses
Table 104. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 105. Vetoquinol Major Business
Table 106. Vetoquinol Modified Live Vaccine Product and Services
Table 107. Vetoquinol Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Vetoquinol Recent Developments/Updates
Table 109. Vetoquinol Competitive Strengths & Weaknesses
Table 110. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
Table 111. Phibro Animal Health Major Business
Table 112. Phibro Animal Health Modified Live Vaccine Product and Services
Table 113. Phibro Animal Health Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Phibro Animal Health Recent Developments/Updates
Table 115. Phibro Animal Health Competitive Strengths & Weaknesses
Table 116. IDT Biologika Basic Information, Manufacturing Base and Competitors
Table 117. IDT Biologika Major Business
Table 118. IDT Biologika Modified Live Vaccine Product and Services
Table 119. IDT Biologika Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. IDT Biologika Recent Developments/Updates
Table 121. IDT Biologika Competitive Strengths & Weaknesses
Table 122. Vaxxinova Basic Information, Manufacturing Base and Competitors
Table 123. Vaxxinova Major Business
Table 124. Vaxxinova Modified Live Vaccine Product and Services
Table 125. Vaxxinova Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Vaxxinova Recent Developments/Updates
Table 127. Vaxxinova Competitive Strengths & Weaknesses
Table 128. KBNP Inc. Basic Information, Manufacturing Base and Competitors
Table 129. KBNP Inc. Major Business
Table 130. KBNP Inc. Modified Live Vaccine Product and Services
Table 131. KBNP Inc. Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. KBNP Inc. Recent Developments/Updates
Table 133. KBNP Inc. Competitive Strengths & Weaknesses
Table 134. China Pharmaceutical Group Animal Health Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 135. China Pharmaceutical Group Animal Health Co., Ltd. Major Business
Table 136. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product and Services
Table 137. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. China Pharmaceutical Group Animal Health Co., Ltd. Recent Developments/Updates
Table 139. China Pharmaceutical Group Animal Health Co., Ltd. Competitive Strengths & Weaknesses
Table 140. Jinyu Bio-technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 141. Jinyu Bio-technology Co., Ltd. Major Business
Table 142. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product and Services
Table 143. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Jinyu Bio-technology Co., Ltd. Recent Developments/Updates
Table 145. Jinyu Bio-technology Co., Ltd. Competitive Strengths & Weaknesses
Table 146. Global Key Players of Modified Live Vaccine Upstream (Raw Materials)
Table 147. Global Modified Live Vaccine Typical Customers
Table 148. Modified Live Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Modified Live Vaccine Picture
Figure 2. World Modified Live Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Modified Live Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Modified Live Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Modified Live Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Modified Live Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 12. India Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 13. Modified Live Vaccine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 16. World Modified Live Vaccine Consumption Market Share by Region (2021-2032)
Figure 17. United States Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. China Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Europe Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. Japan Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. South Korea Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. India Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of Modified Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Modified Live Vaccine Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Modified Live Vaccine Markets in 2025
Figure 27. United States VS China: Modified Live Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Modified Live Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Modified Live Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Modified Live Vaccine Production Market Share 2025
Figure 31. China Based Manufacturers Modified Live Vaccine Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Modified Live Vaccine Production Market Share 2025
Figure 33. World Modified Live Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Modified Live Vaccine Production Value Market Share by Type in 2025
Figure 35. Monovalent Live Attenuated Vaccines
Figure 36. Multivalent Live Attenuated Vaccines
Figure 37. Combination Live Attenuated Vaccines
Figure 38. World Modified Live Vaccine Production Market Share by Type (2021-2032)
Figure 39. World Modified Live Vaccine Production Value Market Share by Type (2021-2032)
Figure 40. World Modified Live Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 41. World Modified Live Vaccine Production Value by Pathogen, (USD Million), 2021 & 2025 & 2032
Figure 42. World Modified Live Vaccine Production Value Market Share by Pathogen in 2025
Figure 43. Viral Live Attenuated Vaccines
Figure 44. Bacterial Live Attenuated Vaccines
Figure 45. Parasitic Live Attenuated Vaccines
Figure 46. World Modified Live Vaccine Production Market Share by Pathogen (2021-2032)
Figure 47. World Modified Live Vaccine Production Value Market Share by Pathogen (2021-2032)
Figure 48. World Modified Live Vaccine Average Price by Pathogen (2021-2032) & (US$/Dose)
Figure 49. World Modified Live Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Modified Live Vaccine Production Value Market Share by Application in 2025
Figure 51. Livestock
Figure 52. Poultry
Figure 53. Companion Animals
Figure 54. Others
Figure 55. World Modified Live Vaccine Production Market Share by Application (2021-2032)
Figure 56. World Modified Live Vaccine Production Value Market Share by Application (2021-2032)
Figure 57. World Modified Live Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 58. Modified Live Vaccine Industry Chain
Figure 59. Modified Live Vaccine Procurement Model
Figure 60. Modified Live Vaccine Sales Model
Figure 61. Modified Live Vaccine Sales Channels, Direct Sales, and Distribution
Figure 62. Methodology
Figure 63. Research Process and Data Source
Figure 1. Modified Live Vaccine Picture
Figure 2. World Modified Live Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Modified Live Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Modified Live Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Modified Live Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Modified Live Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 12. India Modified Live Vaccine Production (2021-2032) & (K Dose)
Figure 13. Modified Live Vaccine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 16. World Modified Live Vaccine Consumption Market Share by Region (2021-2032)
Figure 17. United States Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. China Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Europe Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. Japan Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. South Korea Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. India Modified Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of Modified Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Modified Live Vaccine Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Modified Live Vaccine Markets in 2025
Figure 27. United States VS China: Modified Live Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Modified Live Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Modified Live Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Modified Live Vaccine Production Market Share 2025
Figure 31. China Based Manufacturers Modified Live Vaccine Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Modified Live Vaccine Production Market Share 2025
Figure 33. World Modified Live Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Modified Live Vaccine Production Value Market Share by Type in 2025
Figure 35. Monovalent Live Attenuated Vaccines
Figure 36. Multivalent Live Attenuated Vaccines
Figure 37. Combination Live Attenuated Vaccines
Figure 38. World Modified Live Vaccine Production Market Share by Type (2021-2032)
Figure 39. World Modified Live Vaccine Production Value Market Share by Type (2021-2032)
Figure 40. World Modified Live Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 41. World Modified Live Vaccine Production Value by Pathogen, (USD Million), 2021 & 2025 & 2032
Figure 42. World Modified Live Vaccine Production Value Market Share by Pathogen in 2025
Figure 43. Viral Live Attenuated Vaccines
Figure 44. Bacterial Live Attenuated Vaccines
Figure 45. Parasitic Live Attenuated Vaccines
Figure 46. World Modified Live Vaccine Production Market Share by Pathogen (2021-2032)
Figure 47. World Modified Live Vaccine Production Value Market Share by Pathogen (2021-2032)
Figure 48. World Modified Live Vaccine Average Price by Pathogen (2021-2032) & (US$/Dose)
Figure 49. World Modified Live Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Modified Live Vaccine Production Value Market Share by Application in 2025
Figure 51. Livestock
Figure 52. Poultry
Figure 53. Companion Animals
Figure 54. Others
Figure 55. World Modified Live Vaccine Production Market Share by Application (2021-2032)
Figure 56. World Modified Live Vaccine Production Value Market Share by Application (2021-2032)
Figure 57. World Modified Live Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 58. Modified Live Vaccine Industry Chain
Figure 59. Modified Live Vaccine Procurement Model
Figure 60. Modified Live Vaccine Sales Model
Figure 61. Modified Live Vaccine Sales Channels, Direct Sales, and Distribution
Figure 62. Methodology
Figure 63. Research Process and Data Source
